{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T20:41:49Z","timestamp":1780778509477,"version":"3.54.1"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2021,11,16]],"date-time":"2021-11-16T00:00:00Z","timestamp":1637020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,11,16]],"date-time":"2021-11-16T00:00:00Z","timestamp":1637020800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1007\/s00213-021-06009-0","type":"journal-article","created":{"date-parts":[[2021,11,16]],"date-time":"2021-11-16T10:02:47Z","timestamp":1637056967000},"page":"339-350","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Effectiveness and safety of intravenous valproate in agitation: a systematic review"],"prefix":"10.1007","volume":"239","author":[{"given":"Miriam","family":"Olivola","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serena","family":"Civardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Damiani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolo","family":"Cipriani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Donadeo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierluigi","family":"Politi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natascia","family":"Brondino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,11,16]]},"reference":[{"key":"6009_CR1","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.seizure.2007.04.012","volume":"16","author":"P Agarwal","year":"2007","unstructured":"Agarwal P, Kumar N, Chandra R, Gupta G, Antony AR, Garg N (2007) Randomized study of intravenous valproate and phenytoin in status epilepticus Seizure-European. J Epilepsy 16:527\u2013532. https:\/\/doi.org\/10.1016\/j.seizure.2007.04.012","journal-title":"J Epilepsy"},{"key":"6009_CR2","doi-asserted-by":"publisher","unstructured":"Amiri-Nikpour MR, Nazarbaghi S, Eftekhari P, Mohammadi S, Dindarian S, Bagheri M, Mohammadi H (2018) Sodium valproate compared to phenytoin in treatment of status epilepticus. Brain and Behavior 8. https:\/\/doi.org\/10.1002\/brb3.951","DOI":"10.1002\/brb3.951"},{"key":"6009_CR3","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1345\/aph.19264","volume":"34","author":"GD Anderson","year":"2000","unstructured":"Anderson GD, Lin Y, Temkin NR, Fischer JH, Winn HR (2000) Incidence of intravenous site reactions in neurotrauma patients receiving valproate or phenytoin. Ann Pharmacother 34:697\u2013702","journal-title":"Ann Pharmacother"},{"key":"6009_CR4","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1097\/yic.0000000000000064","volume":"30","author":"S Asadollahi","year":"2015","unstructured":"Asadollahi S, Heidari K, Hatamabadi H, Vafaee R, Yunesian S, Azadbakht A, Mirmohseni L (2015) Efficacy and safety of valproic acid versus haloperidol in patients with acute agitation: results of a randomized, double-blind, parallel-group trial. Int Clin Psychopharmacol 30:142\u2013150. https:\/\/doi.org\/10.1097\/yic.0000000000000064","journal-title":"Int Clin Psychopharmacol"},{"key":"6009_CR5","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.eurpsy.2019.01.014","volume":"57","author":"M Bak","year":"2019","unstructured":"Bak M et al (2019) The pharmacological management of agitated and aggressive behaviour: a systematic review and meta-analysis. Eur Psychiatry 57:78\u2013100. https:\/\/doi.org\/10.1016\/j.eurpsy.2019.01.014","journal-title":"Eur Psychiatry"},{"key":"6009_CR6","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/j.ajem.2012.10.014","volume":"31","author":"B Bakhshayesh","year":"2013","unstructured":"Bakhshayesh B, Saadat SMS, Rezania K, Hatamian H, Hossieninezhad M (2013) A randomized open-label study of sodium valproate vs sumatriptan and metoclopramide for prolonged migraine headache. Am J Emerg Med 31:540\u2013544. https:\/\/doi.org\/10.1016\/j.ajem.2012.10.014","journal-title":"Am J Emerg Med"},{"key":"6009_CR7","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1097\/WNF.0000000000000265","volume":"41","author":"C Battaglia","year":"2018","unstructured":"Battaglia C, Averna R, Labonia M, Riccioni A, Vicari S (2018) Intravenous valproic acid add-on therapy in acute agitation adolescents with suspected substance abuse: a report of six cases. Clin Neuropharmacol 41:38\u201342. https:\/\/doi.org\/10.1097\/WNF.0000000000000265","journal-title":"Clin Neuropharmacol"},{"key":"6009_CR8","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1017\/S1461145703003535","volume":"6","author":"CL Bowden","year":"2003","unstructured":"Bowden CL (2003) Acute and maintenance treatment with mood stabilizers. Int J Neuropsychopharmacol 6:269\u2013275. https:\/\/doi.org\/10.1017\/S1461145703003535","journal-title":"Int J Neuropsychopharmacol"},{"key":"6009_CR9","doi-asserted-by":"publisher","first-page":"53S","DOI":"10.1097\/00004714-199202001-00008","volume":"12","author":"JR Calabrese","year":"1992","unstructured":"Calabrese JR, Markovitz PJ, Kimmel SE, Wagner SC (1992) Spectrum of efficacy of valproate in 78 rapid-cycling bipolar patients. J Clin Psychopharmacol 12:53S-56S. https:\/\/doi.org\/10.1097\/00004714-199202001-00008","journal-title":"J Clin Psychopharmacol"},{"key":"6009_CR10","first-page":"S57","volume":"38","author":"JR Calabrese","year":"1993","unstructured":"Calabrese JR, Rapport DJ, Kimmel SE, Reece B, Woyshville MJ (1993) Rapid cycling bipolar disorder and its treatment with valproate. Can J Psychiatry 38:S57-61","journal-title":"Can J Psychiatry"},{"key":"6009_CR11","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1111\/j.1468-1331.2011.03420.x","volume":"18","author":"WB Chen","year":"2011","unstructured":"Chen WB et al (2011) Valproate versus diazepam for generalized convulsive status epilepticus: a pilot study. Eur J Neurol 18:1391\u20131396. https:\/\/doi.org\/10.1111\/j.1468-1331.2011.03420.x","journal-title":"Eur J Neurol"},{"key":"6009_CR12","first-page":"173","volume":"44","author":"HS Duggal","year":"2002","unstructured":"Duggal HS, Jagadheesan K, Gupta S, Basu S, Akhtar S, Nizamie HS (2002) Intravenous valproate: a new perspective in the treatment of manic symptoms. Indian J Psychiatry 44:173\u2013176","journal-title":"Indian J Psychiatry"},{"key":"6009_CR13","first-page":"150","volume":"38","author":"M Foroughipour","year":"2013","unstructured":"Foroughipour M, Ghandehari K, Khazaei M, Ahmadi F, Shariatinezhad K, Ghandehari K (2013) Randomized clinical trial of intravenous valproate (Orifil) and dexamethasone in patients with migraine disorder. Iran J Med Sci 38:150\u2013155","journal-title":"Iran J Med Sci"},{"key":"6009_CR14","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1212\/wnl.0000000000000223","volume":"82","author":"BW Friedman","year":"2014","unstructured":"Friedman BW et al (2014) Randomized trial of IV valproate vs metoclopramide vs ketorolac for acute migraine. Neurology 82:976\u2013983. https:\/\/doi.org\/10.1212\/wnl.0000000000000223","journal-title":"Neurology"},{"key":"6009_CR15","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.jcrc.2016.09.006","volume":"37","author":"DJ Gagnon","year":"2017","unstructured":"Gagnon DJ et al (2017) Valproate for agitation in critically ill patients: a retrospective study. J Crit Care 37:119\u2013125. https:\/\/doi.org\/10.1016\/j.jcrc.2016.09.006","journal-title":"J Crit Care"},{"key":"6009_CR16","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1159\/000363344","volume":"70","author":"A Ghaleiha","year":"2014","unstructured":"Ghaleiha A et al (2014) Oral loading of sodium valproate compared to intravenous loading and oral maintenance inacutely manic bipolar patients. Neuropsychobiology 70:29\u201335. https:\/\/doi.org\/10.1159\/000363344","journal-title":"Neuropsychobiology"},{"key":"6009_CR17","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1111\/j.1600-0404.2008.01097.x","volume":"118","author":"R Gilad","year":"2008","unstructured":"Gilad R, Izkovitz N, Dabby R, Rapoport A, Sadeh M, Weller B, Lampl Y (2008) Treatment of status epilepticus and acute repetitive seizures with i.v. valproic acid vs phenytoin. Acta Neurol Scand 118:296\u2013300. https:\/\/doi.org\/10.1111\/j.1600-0404.2008.01097.x","journal-title":"Acta Neurol Scand"},{"key":"6009_CR18","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1097\/00004714-199908000-00003","volume":"19","author":"H Grunze","year":"1999","unstructured":"Grunze H, Erfurth A, Amann B, Giupponi G, Kammerer C, Walden J (1999) Intravenous valproate loading in acutely manic and depressed bipolar I patients. J Clin Psychopharmacol 19:303\u2013309. https:\/\/doi.org\/10.1097\/00004714-199908000-00003","journal-title":"J Clin Psychopharmacol"},{"key":"6009_CR19","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1176\/jnp.10.3.365","volume":"10","author":"DM Hilty","year":"1998","unstructured":"Hilty DM, Rodriguez GD, Hales RE (1998) Intravenous valproate for rapid stabilization of agitation in neuropsychiatric disorders. J Neuropsychiatry Clin Neurosci 10:365\u2013366. https:\/\/doi.org\/10.1176\/jnp.10.3.365","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"6009_CR20","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1038\/npp.2009.202","volume":"35","author":"E Hollander","year":"2010","unstructured":"Hollander E et al (2010) Divalproex sodium vs placebo for the treatment of irritability in children and adolescents with autism spectrum disorders. Neuropsychopharmacology 35:990\u2013998. https:\/\/doi.org\/10.1038\/npp.2009.202","journal-title":"Neuropsychopharmacology"},{"key":"6009_CR21","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1038\/sj.npp.1300153","volume":"28","author":"E Hollander","year":"2003","unstructured":"Hollander E et al (2003) Divalproex in the treatment of impulsive aggression: efficacy in cluster B personality disorders. Neuropsychopharmacology 28:1186\u20131197. https:\/\/doi.org\/10.1038\/sj.npp.1300153","journal-title":"Neuropsychopharmacology"},{"key":"6009_CR22","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1056\/NEJMoa1905795","volume":"381","author":"J Kapur","year":"2019","unstructured":"Kapur J et al (2019) Randomized trial of three anticonvulsant medications for status epilepticus. N Engl J Med 381:2103\u20132113. https:\/\/doi.org\/10.1056\/NEJMoa1905795","journal-title":"N Engl J Med"},{"key":"6009_CR23","doi-asserted-by":"publisher","first-page":"138","DOI":"10.15441\/ceem.16.199","volume":"4","author":"N Karimi","year":"2017","unstructured":"Karimi N, Tavakoli M, Charati JY, Shamsizade M (2017) Single-dose intravenous sodium valproate (depakine) versus dexamethasone for the treatment of acute migraine headache: a double-blind randomized clinical trial. Clin Exp Emerg Med 4:138\u2013145. https:\/\/doi.org\/10.15441\/ceem.16.199","journal-title":"Clin Exp Emerg Med"},{"key":"6009_CR24","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1111\/bcp.13604","volume":"84","author":"K Kongpakwattana","year":"2018","unstructured":"Kongpakwattana K, Sawangjit R, Tawankanjanachot I, Bell JS, Hilmer SN, Chaiyakunapruk N (2018) Pharmacological treatments for alleviating agitation in dementia: a systematic review and network meta-analysis. Br J Clin Pharmacol 84:1445\u20131456. https:\/\/doi.org\/10.1111\/bcp.13604","journal-title":"Br J Clin Pharmacol"},{"key":"6009_CR25","first-page":"707","volume":"124","author":"PA Lambert","year":"1966","unstructured":"Lambert PA, Carraz G, Borselli S, Carbel S (1966) Neuropsychotropic action of a new anti-epileptic agent: depamide. Ann Med Psychol (paris) 124:707\u2013710","journal-title":"Ann Med Psychol (paris)"},{"key":"6009_CR26","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1111\/j.1526-4610.2005.05009.x","volume":"45","author":"T Leniger","year":"2005","unstructured":"Leniger T, Pageler L, Stude P, Diener HC, Limmroth V (2005) Comparison of intravenous valproate with intravenous lysine-acetylsalicylic acid in acute migraine attacks. Headache 45:42\u201346. https:\/\/doi.org\/10.1111\/j.1526-4610.2005.05009.x","journal-title":"Headache"},{"key":"6009_CR27","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1080\/00207454.2020.1732967","volume":"131","author":"I Liampas","year":"2021","unstructured":"Liampas I, Siokas V, Brotis A, Zintzaras E, Stefanidis I, Dardiotis E (2021) Intravenous sodium valproate in status epilepticus: review and Meta-analysis. Int J Neurosci 131:70\u201384. https:\/\/doi.org\/10.1080\/00207454.2020.1732967","journal-title":"Int J Neurosci"},{"key":"6009_CR28","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1016\/j.ejpn.2012.01.012","volume":"16","author":"RA Malamiri","year":"2012","unstructured":"Malamiri RA, Ghaempanah M, Khosroshahi N, Nikkhah A, Bavarian B, Ashrafi MR (2012) Efficacy and safety of intravenous sodium valproate versus phenobarbital in controlling convulsive status epilepticus and acute prolonged convulsive seizures in children: a randomised trial. Eur J Paediatr Neurol 16:536\u2013541. https:\/\/doi.org\/10.1016\/j.ejpn.2012.01.012","journal-title":"Eur J Paediatr Neurol"},{"key":"6009_CR29","doi-asserted-by":"publisher","unstructured":"Mazaheri S, Poorolajal J, Hosseinzadeh A, Fazlian MM (2015) Effect of intravenous sodium valproate vs dexamethasone on acute migraine headache: a double blind randomized clinical trial. PLoS ONE 10. https:\/\/doi.org\/10.1371\/journal.pone.0120229","DOI":"10.1371\/journal.pone.0120229"},{"key":"6009_CR30","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.yebeh.2017.07.005","volume":"76","author":"UK Misra","year":"2017","unstructured":"Misra UK, Dubey D, Kalita J (2017) Comparison of lacosamide versus sodium valproate in status epilepticus: a pilot study. Epilepsy Behav 76:110\u2013113. https:\/\/doi.org\/10.1016\/j.yebeh.2017.07.005","journal-title":"Epilepsy Behav"},{"key":"6009_CR31","first-page":"e123","volume":"3","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG, Group P (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement. Open Med 3:e123-130","journal-title":"Open Med"},{"key":"6009_CR32","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.seizure.2019.01.015","volume":"65","author":"D Nene","year":"2019","unstructured":"Nene D et al (2019) Comparing the efficacy of sodium valproate and levetiracetam following initial lorazepam in elderly patients with generalized convulsive status epilepticus (GCSE): a prospective randomized controlled pilot study. Seizure-European J Epilepsy 65:111\u2013117. https:\/\/doi.org\/10.1016\/j.seizure.2019.01.015","journal-title":"Seizure-European J Epilepsy"},{"key":"6009_CR33","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.psc.2017.05.002","volume":"40","author":"A New","year":"2017","unstructured":"New A, Tucci VT, Rios J (2017) A modern-day fight club? The stabilization and management of acutely agitated patients in the emergency department. Psychiatr Clin North Am 40:397\u2013410. https:\/\/doi.org\/10.1016\/j.psc.2017.05.002","journal-title":"Psychiatr Clin North Am"},{"key":"6009_CR34","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1592\/phco.20.1.88.34657","volume":"20","author":"JW Norton","year":"2000","unstructured":"Norton JW, Quarles E (2000) Intravenous valproate in neuropsychiatry. Pharmacotherapy 20:88\u201392. https:\/\/doi.org\/10.1592\/phco.20.1.88.34657","journal-title":"Pharmacotherapy"},{"key":"6009_CR35","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1177\/1060028020947173","volume":"55","author":"NJ Quinn","year":"2021","unstructured":"Quinn NJ, Hohlfelder B, Wanek MR, Duggal A, Torbic H (2021) Prescribing practices of valproic acid for agitation and delirium in the intensive care unit. Ann Pharmacother 55:311\u2013317. https:\/\/doi.org\/10.1177\/1060028020947173","journal-title":"Ann Pharmacother"},{"key":"6009_CR36","first-page":"171","volume":"39","author":"A Rahimdel","year":"2014","unstructured":"Rahimdel A, Mellat A, Zeinali A, Jafari E, Ayatollahi P (2014) Comparison between intravenous sodium valproate and subcutaneous sumatriptan for treatment of acute migraine attacks; double-blind randomized clinical trial. Iran J Med Sci 39:171\u2013177","journal-title":"Iran J Med Sci"},{"key":"6009_CR37","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.14260\/jemds\/2019\/328","volume":"8","author":"S Rajasekar","year":"2019","unstructured":"Rajasekar S, Selvakumar P, Nazar RM (2019) Sodium valproate versus fosphenytoin for status epilepticus in children - a randomized control trial. J Evol Med Dent Sci-Jemds 8:1474\u20131478. https:\/\/doi.org\/10.14260\/jemds\/2019\/328","journal-title":"J Evol Med Dent Sci-Jemds"},{"key":"6009_CR38","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1097\/00019442-200108000-00017","volume":"9","author":"WT Regenold","year":"2001","unstructured":"Regenold WT, Prasad M (2001) Uses of intravenous valproate in geriatric psychiatry. Am J Geriatr Psychiatry 9:306\u2013308","journal-title":"Am J Geriatr Psychiatry"},{"key":"6009_CR39","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1177\/0091270009347870","volume":"50","author":"S Sekhar","year":"2010","unstructured":"Sekhar S, Kalra B, Mendhekar DN, Tekur U (2010) Efficacy of sodium valproate and haloperidol in the management of acute mania: a randomized open-label comparative study. J Clin Pharmacol 50:688\u2013692. https:\/\/doi.org\/10.1177\/0091270009347870","journal-title":"J Clin Pharmacol"},{"key":"6009_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jad.2009.10.033","volume":"122","author":"LA Smith","year":"2010","unstructured":"Smith LA, Cornelius VR, Azorin JM, Perugi G, Vieta E, Young AH, Bowden CL (2010) Valproate for the treatment of acute bipolar depression: systematic review and meta-analysis. J Affect Disord 122:1\u20139. https:\/\/doi.org\/10.1016\/j.jad.2009.10.033","journal-title":"J Affect Disord"},{"key":"6009_CR41","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1007\/s40263-016-0388-6","volume":"30","author":"Y Su","year":"2016","unstructured":"Su Y et al (2016) Phenobarbital versus valproate for generalized convulsive status epilepticus in adults: a prospective randomized controlled trial in China. CNS Drugs 30:1201\u20131207. https:\/\/doi.org\/10.1007\/s40263-016-0388-6","journal-title":"CNS Drugs"},{"key":"6009_CR42","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1067\/mem.2003.195","volume":"41","author":"DA Tanen","year":"2003","unstructured":"Tanen DA, Miller S, French T, Riffenburgh RH (2003) Intravenous sodium valproate versus prochlorperazine for the emergency department treatment of acute migraine headaches: a prospective, randomized, double-blind trial. Ann Emerg Med 41:847. https:\/\/doi.org\/10.1067\/mem.2003.195","journal-title":"Ann Emerg Med"},{"key":"6009_CR43","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/s0920-1211(99)00005-4","volume":"35","author":"V Venkataraman","year":"1999","unstructured":"Venkataraman V, Wheless JW (1999) Safety of rapid intravenous infusion of valproate loading doses in epilepsy patients. Epilepsy Res 35:147\u2013153. https:\/\/doi.org\/10.1016\/s0920-1211(99)00005-4","journal-title":"Epilepsy Res"},{"key":"6009_CR44","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1007\/s13312-020-1755-4","volume":"57","author":"V Vignesh","year":"2020","unstructured":"Vignesh V, Rameshkumar R, Mahadevan S (2020) Comparison of phenytoin, valproate and levetiracetam in pediatric convulsive status epilepticus: a randomized double-blind controlled clinical trial. Indian Pediatr 57:222\u2013227. https:\/\/doi.org\/10.1007\/s13312-020-1755-4","journal-title":"Indian Pediatr"},{"key":"6009_CR45","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1111\/ane.13325","volume":"142","author":"F Wang","year":"2020","unstructured":"Wang F, Zhang H, Wang L, Cao Y, He Q (2020) Intravenous sodium valproate for acute migraine in the emergency department: a meta-analysis. Acta Neurol Scand 142:521\u2013530. https:\/\/doi.org\/10.1111\/ane.13325","journal-title":"Acta Neurol Scand"},{"key":"6009_CR46","unstructured":"Wangemann M, Wolf C, Retzow A (1997) Replacement of oral valproate with intravenous valproate: a study on dose finding and bioavailability. Eur J Clin Res:209\u2013215"},{"key":"6009_CR47","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1212\/01.wnl.0000142077.14142.aa","volume":"63","author":"JW Wheless","year":"2004","unstructured":"Wheless JW, Vazquez BR, Kanner AM, Ramsay RE, Morton L, Pellock JM (2004) Rapid infusion with valproate sodium is well tolerated in patients with epilepsy. Neurology 63:1507\u20131508. https:\/\/doi.org\/10.1212\/01.wnl.0000142077.14142.aa","journal-title":"Neurology"}],"updated-by":[{"DOI":"10.1007\/s00213-022-06061-4","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2022,1,13]],"date-time":"2022-01-13T00:00:00Z","timestamp":1642032000000}}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-021-06009-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00213-021-06009-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-021-06009-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,29]],"date-time":"2022-01-29T03:10:50Z","timestamp":1643425850000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00213-021-06009-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,16]]},"references-count":47,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["6009"],"URL":"https:\/\/doi.org\/10.1007\/s00213-021-06009-0","relation":{"correction":[{"id-type":"doi","id":"10.1007\/s00213-022-06061-4","asserted-by":"object"}]},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,16]]},"assertion":[{"value":"14 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 October 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 November 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2022","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s00213-022-06061-4","URL":"https:\/\/doi.org\/10.1007\/s00213-022-06061-4","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}